Brief: GSK Says Nucala Receives Positive Reimbursement Recommendation From CDA-AMC
18/08/2026 15:22
BRIEF-GSK Says Nucala Receives Positive Reimbursement Recommendation From CDA-AMC Aug 18 (Reuters) - GSK plc GSK.L:
GSK: NUCALA (MEPOLIZUMAB) RECEIVES POSITIVE REIMBURSEMENT RECOMMENDATION FROM CDA-AMC FOR ADULTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
((Reuters.Briefs@thomsonreuters.com;))